Bioprojet SCR - Product Pipeline Review - 2015

  • ID: 3230977
  • Company Profile
  • 27 pages
  • Global Markets Direct
1 of 4
Bioprojet SCR - Product Pipeline Review - 2015

Summary

This, ‘Bioprojet SCR - Product Pipeline Review - 2015’, provides an overview of the Bioprojet SCR’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Bioprojet SCR’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Bioprojet SCR including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Bioprojet SCR’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Bioprojet SCR’s pipeline products

Reasons to buy

- Evaluate Bioprojet SCR’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Bioprojet SCR in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Bioprojet SCR’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Bioprojet SCR and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Bioprojet SCR
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Bioprojet SCR and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables
List of Figures
Bioprojet SCR Snapshot
Bioprojet SCR Overview
Key Information
Key Facts
Bioprojet SCR - Research and Development Overview
Key Therapeutic Areas
Bioprojet SCR - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Bioprojet SCR - Pipeline Products Glance
Bioprojet SCR - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Bioprojet SCR - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Bioprojet SCR - Drug Profiles
pitolisant
Product Description
Mechanism of Action
R&D Progress
dexecadotril
Product Description
Mechanism of Action
R&D Progress
BP-1.4979
Product Description
Mechanism of Action
R&D Progress
BP-1.3656
Product Description
Mechanism of Action
R&D Progress
Bioprojet SCR - Pipeline Analysis
Bioprojet SCR - Pipeline Products by Target
Bioprojet SCR - Pipeline Products by Route of Administration
Bioprojet SCR - Pipeline Products by Molecule Type
Bioprojet SCR - Pipeline Products by Mechanism of Action
Bioprojet SCR - Recent Pipeline Updates
Bioprojet SCR - Dormant Projects
Bioprojet SCR - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Bioprojet SCR, Key Information
Bioprojet SCR, Key Facts
Bioprojet SCR - Pipeline by Indication, 2015
Bioprojet SCR - Pipeline by Stage of Development, 2015
Bioprojet SCR - Monotherapy Products in Pipeline, 2015
Bioprojet SCR - Pre-Registration, 2015
Bioprojet SCR - Phase III, 2015
Bioprojet SCR - Phase II, 2015
Bioprojet SCR - Phase I, 2015
Bioprojet SCR - Pipeline by Target, 2015
Bioprojet SCR - Pipeline by Route of Administration, 2015
Bioprojet SCR - Pipeline by Molecule Type, 2015
Bioprojet SCR - Pipeline Products by Mechanism of Action, 2015
Bioprojet SCR - Recent Pipeline Updates, 2015
Bioprojet SCR - Dormant Developmental Projects,2015
Bioprojet SCR, Subsidiaries

List of Figures
Bioprojet SCR - Pipeline by Top 10 Indication, 2015
Bioprojet SCR - Pipeline by Stage of Development, 2015
Bioprojet SCR - Monotherapy Products in Pipeline, 2015
Bioprojet SCR - Pipeline by Top 10 Target, 2015
Bioprojet SCR - Pipeline by Top 10 Molecule Type, 2015
Bioprojet SCR - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll